Vaping rivals, quitters cloud Japan Tobacco's cigarette sales

TOKYO (Reuters) - Japan Tobacco Inc said it expected a steeper decline in cigarette sales at home than previously estimated, after earlier reporting disappointing results, as more smokers quit or defect to "heat-not-burn" tobacco products.

AstraZeneca asthma drug tralokinumab disappoints again

LONDON (Reuters) - An experimental biotech drug for severe asthma from AstraZeneca has failed in further clinical tests, following an earlier setback in May and disappointing results with a similar drug at Roche.

Indivior drug to fight opioid addiction recommended by U.S. panel

(Reuters) - Indivior's experimental drug to help fight America's growing opioid addiction crisis has been recommended for approval by a U.S. advisory panel, boosting its sales prospects as competitors threaten revenues from an older product.